.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Cantor Fitzgerald
Farmers Insurance
Boehringer Ingelheim
Queensland Health
Argus Health
Federal Trade Commission
Harvard Business School
Merck
QuintilesIMS

Generated: July 26, 2017

DrugPatentWatch Database Preview

LEVETIRACETAM IN SODIUM CHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Levetiracetam In Sodium Chloride, and when can generic versions of Levetiracetam In Sodium Chloride launch?

Levetiracetam In Sodium Chloride is a drug marketed by Hq Speciality Pharma and Aurobindo Pharma Ltd and is included in two NDAs.

The generic ingredient in LEVETIRACETAM IN SODIUM CHLORIDE is levetiracetam. There are thirty-five drug master file entries for this compound. Ninety-six suppliers are listed for this compound. Additional details are available on the levetiracetam profile page.

Summary for Tradename: LEVETIRACETAM IN SODIUM CHLORIDE

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list2
Bulk Api Vendors: see list78
Clinical Trials: see list2,733
Patent Applications: see list1,878
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LEVETIRACETAM IN SODIUM CHLORIDE at DailyMed

Pharmacology for Tradename: LEVETIRACETAM IN SODIUM CHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hq Speciality Pharma
LEVETIRACETAM IN SODIUM CHLORIDE
levetiracetam
INJECTABLE;IV (INFUSION)202543-001Nov 9, 2011APRXYesYes► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
LEVETIRACETAM IN SODIUM CHLORIDE
levetiracetam
INJECTABLE;IV (INFUSION)207160-001Jan 4, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Hq Speciality Pharma
LEVETIRACETAM IN SODIUM CHLORIDE
levetiracetam
INJECTABLE;IV (INFUSION)202543-002Nov 9, 2011APRXYesYes► Subscribe► Subscribe► Subscribe
Hq Speciality Pharma
LEVETIRACETAM IN SODIUM CHLORIDE
levetiracetam
INJECTABLE;IV (INFUSION)202543-003Nov 9, 2011APRXYesYes► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
LEVETIRACETAM IN SODIUM CHLORIDE
levetiracetam
INJECTABLE;IV (INFUSION)207160-003Jan 4, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Healthtrust
Fuji
Cantor Fitzgerald
Merck
Boehringer Ingelheim
Cerilliant
QuintilesIMS
Federal Trade Commission
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot